IP Library Patent Application 11712332
Patent Application
App. No. 11/712,332

Antimicrobial medical devices

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/712,332
Abstract

Antimicrobial medical devices are prepared with a complexed antimicrobial agent which enhances the adherence of the antimicrobial agent to the medical device.

Claims (33)

1 . An antimicrobial medical device comprising:

a medical device; and

a complexed antimicrobial agent located on at least a portion of a surface of the medical device.

2 . An antimicrobial medical device as in claim 1 wherein the complexed antimicrobial agent comprises at least one adherence-enhancing agent selected from the group consisting of N-methylglucamine, L-arginine, sodium lauryl sulfate, beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin, ethanolamine, triethanolamine, diethanolamine, sodium benzoate, sodium methyl 4-hydroxybenzoate, and combinations thereof.

3 . An antimicrobial medical device as in claim 1 wherein the complexed antimicrobial agent comprises at least one antimicrobial agent selected from the group consisting of antibiotics, antiseptics, disinfectants and combinations thereof.

4 . An antimicrobial medical device as in claim 3 wherein the at least one antimicrobial agent is an antiseptic selected from the group consisting of hexachlorophene, chlorhexidine, cyclohexidine, iodine, povidone-iodine, p-chloro-m-xylenol, triclosan, nitrofurantoin, nitrofurazone, methenamine, glutaraldehyde, formaldehyde, and alcohols.

5 . An antimicrobial medical device as in claim 1 wherein the medical device is selected from the group consisting of staples, clips, drug delivery devices, stents, pins, screws, sutures, prosthetic ligaments, prosthetic tendons, woven mesh, gauze, dressings, and growth matrices.

6 . An antimicrobial suture comprising:

at least one filament; and

a complexed antimicrobial agent located on at least a portion of a surface of the at least one filament.

7 . An antimicrobial suture as in claim 6 wherein the suture is selected from the group consisting of monofilament sutures and multifilament sutures.

8 . An antimicrobial suture as in claim 6 wherein the at least one filament comprises a polyolefin.

9 . An antimicrobial suture as in claim 6 wherein the at least one filament is made from a synthetic absorbable polymer derived from one or more monomers selected from the group consisting of glycolide, lactide, caprolactone, trimethylene carbonate, tetramethylene carbonate, dioxanone, and combinations thereof.

10 . An antimicrobial suture as in claim 6 wherein the at least one filament further comprises a coating comprising at least one film-forming polymer.

11 . An antimicrobial suture as in claim 10 wherein the coating further comprises an additive selected from the group consisting of fatty acid salts and salts of fatty acid esters.

12 . An antimicrobial suture as in claim 6 wherein the complexed antimicrobial agent comprises at least one antimicrobial agent selected from the group consisting of antibiotics, antiseptics, disinfectants and combinations thereof.

13 . An antimicrobial suture as in claim 12 wherein the at least one antimicrobial agent is an antiseptic selected from the group consisting of hexachlorophene, chlorhexidine, cyclohexidine, iodine, povidone-iodine, p-chloro-m-xylenol, triclosan, nitrofurantoin, nitrofurazone, methenamine, glutaraldehyde, formaldehyde, and alcohols.

14 . An antimicrobial suture as in claim 6 wherein the complexed antimicrobial agent comprises at least one adherence-enhancing agent selected from the group consisting of N-methylglucamine, L-arginine, sodium lauryl sulfate, beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin, ethanolamine, triethanolamine, diethanolamine, sodium benzoate, sodium methyl 4-hydroxybenzoate, and combinations thereof.

15 . A method comprising:

providing a suture having at least one filament;

applying an antimicrobial solution comprising at least one antimicrobial agent, at least one adherence-enhancing agent, and at least one solvent to the at least one filament; and

removing the at least one solvent leaving a complexed antimicrobial agent on at least a portion of a surface of the suture.

16 . The method of claim 15 wherein the step of applying the antimicrobial solution utilizes an antimicrobial solution containing at least one antimicrobial agent selected from the group consisting of antibiotics, antiseptics, disinfectants and combinations thereof.

17 . The method of claim 15 wherein the step of applying the antimicrobial solution utilizes an antimicrobial solution comprising triclosan as the at least one antimicrobial agent.

18 . The method of claim 15 wherein the step of applying the antimicrobial solution utilizes an antimicrobial solution having at least one adherence-enhancing agent selected from the group consisting of N-methylglucamine, L-arginine, sodium lauryl sulfate, beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin, ethanolamine, triethanolamine, diethanolamine, sodium benzoate, sodium methyl 4-hydroxybenzoate, and combinations thereof.

19 . The method of claim 15 wherein the step of applying the antimicrobial solution utilizes an antimicrobial solution having an ethanolamine as the at least one adherence-enhancing agent.

20 . The method of claim 15 wherein the step of applying the antimicrobial solution utilizes an antimicrobial solution having a cyclodextrin as the at least one adherence-enhancing agent.

21 . The method of claim 15 wherein the step of applying the antimicrobial solution utilizes an antimicrobial solution having at least one solvent selected from the group consisting of methylene chloride, chloroform, ethyl acetate, methyl acetate, N-methyl 2-pyrrolidone, 2-pyrrolidone, propylene glycol, tetrahydrofuran (THF), acetone, oleic acid, methyl ethyl ketone, water, and mixtures thereof.

22 . The method of claim 15 wherein the step of applying the antimicrobial solution comprises applying an antimicrobial solution containing triclosan as the at least one antimicrobial agent, an ethanolamine as the at least one adherence-enhancing agent, and methylene chloride as the at least one solvent.

23 . The method of claim 15 wherein the step of applying the antimicrobial solution comprises applying an antimicrobial solution containing triclosan as the at least one antimicrobial agent, a cyclodextrin as the at least one adherence-enhancing agent, and methylene chloride as the at least one solvent.

24 . A method of suturing a wound comprising:

a) providing a needled suture having on at least a portion of its surface a complexed antimicrobial agent and;

b) passing said needled suture through approximated wound tissue to create wound closure.

Assignments (2)
CHANGE OF NAME Recorded Oct 2, 2012
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 029065/0448 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2007
From: BELCHEVA, NADYA; KENNEDY, JOHN
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 019343/0339 →